How does it compare to other options
Work with us on payor market strategy: Contact us Connect with the author, Ryan Peterson, on LinkedIn
This innovative multi-receptor activation approach is designed to address the complex pathophysiology of obesity by enhancing energy expenditure, improving glucose homeostasis, and promoting satiety, thereby facilitating sustainable weight loss
You need to meet one of three BMI-based criteria, complete a prior authorization through the program's central processor, and use the medication alongside structured nutrition and physical activity
Licensed provider reviews and determines eligibility
BPC-157 and TB-500 promote angiogenesis and fibroblast activation, stimulating new vessel formation and collagen deposition